Treatment of Arthralgia in Psoriatic Arthritis with Yokuinin-to / 日本東洋医学雑誌

ABSTRACT

Oral administration of Yokuinin-to was added to the previous drugs in 4 patients with psoriatic arthritis. All of the cases responded to the therapy without adverse effects. In 3 of 4 cases, the previous drugs, i. e, corticosteroids, etretinate, or non-steroidal anti-inflammatory drugs (NSAIDs), were able to be discontinued after the beginning of the Yokuinin-to therapy. The remainder had favorable control of arthralgia with Yokuinin-to alone. During the course of the therapy, there were no considerable changes in skin eruption in all 4 cases. We consider Yokuinin-to one of the first drugs of choice in the treatment of arthralgia in patients with psoriatic arthritis.